- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Androgen Deprivation
Total 1377 results
-
University of ChicagoNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterFerring PharmaceuticalsActive, not recruitingProstate Cancer | Prostatic AdenocarcinomaUnited States
-
Sohag UniversityNot yet recruiting
-
M.D. Anderson Cancer CenterJanssen Scientific Affairs, LLCNot yet recruitingProstate Cancer | Prostatectomy | Androgen Axis SuppressionUnited States
-
European Institute of OncologyRecruitingOligometastatic Prostate CancerItaly
-
VA Greater Los Angeles Healthcare SystemActive, not recruiting
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Pedro Barata, MD, MScESSA Pharma Inc.Not yet recruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-sensitive Prostate Cancer (mHSPC)United States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Recruiting
-
Istituto Clinico HumanitasRecruitingOligorecurrent and Oligoprogressive Prostate Cancer PatientsItaly
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Xian-Janssen Pharmaceutical Ltd.Not yet recruitingProstate Cancer | Biochemical Recurrence | High RiskChina
-
Janssen Research & Development, LLCRecruitingMetastatic Castrate-sensitive Prostate CancerUnited States, France, Mexico, Germany, Australia, Brazil, Canada, China, Poland
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Active, not recruiting
-
Olof AkreRecruitingProstatic NeoplasmsDenmark, Norway, Finland, Sweden
-
Centre Georges Francois LeclercTerminated
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawn
-
National Taiwan University HospitalUnknown
-
Andrew McDonaldNational Cancer Institute (NCI)Active, not recruitingProstate AdenocarcinomaUnited States
-
Chinese University of Hong KongActive, not recruitingProstate CancerHong Kong
-
BayerRecruiting
-
BayerOrion Corporation, Orion PharmaActive, not recruitingDarolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer (ARANOTE)Prostatic NeoplasmsChina, Russian Federation, Taiwan, Latvia, India, Australia, Brazil, Canada, Chile, Lithuania, New Zealand, Peru, South Africa, Spain, Ukraine
-
University of CincinnatiJanssen, LPRecruitingProstate CancerUnited States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...First Affiliated Hospital of Zhejiang University; The First Affiliated Hospital...Recruiting
-
Duke UniversityCompleted
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Jiangsu HengRui Medicine Co., Ltd.RecruitingProstate Cancer | Biochemical RecurrenceChina
-
Astellas Pharma IncPfizerCompleted
-
Changhai HospitalRecruiting
-
University of VirginiaRecruitingProstate Cancer | Prostate AdenocarcinomaUnited States
-
Advocate Health CareRecruitingProstate AdenocarcinomaUnited States
-
Norwegian School of Sport SciencesKing's College London; Oslo University Hospital; Rigshospitalet, Denmark; University... and other collaboratorsTerminatedProstate Cancer | Resistance Exercise | Androgen Deprivation TherapyNorway
-
Janssen Research & Development, LLCActive, not recruiting
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstate CancerUnited States, France, Poland, Ukraine, United Kingdom, China, Spain, Argentina, Israel, Mexico, Romania, Turkey, Korea, Republic of, Japan, Sweden, Canada, Russian Federation, Brazil, Germany, Hungary, Czechia, Australia
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUniversity of Bologna; Catholic University of the Sacred Heart; Michigan State... and other collaboratorsCompleted
-
UNICANCERBayerRecruitingProstate Cancer MetastaticSpain, France, Ireland, Belgium
-
Weill Medical College of Cornell UniversityConvergent Therapeutics, Inc.WithdrawnProstate Cancer MetastaticUnited States
-
University of MiamiVarian Medical SystemsNot yet recruiting
-
University of ChicagoRecruitingProstate Cancer | Prostate AdenocarcinomaUnited States
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingProstate CancerCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Neoplasm in Lymph Node | Prostate Ductal Adenocarcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Adenocarcinoma AJCC v7United States
-
Jonsson Comprehensive Cancer CenterViewray Inc.Active, not recruitingPSA Progression | Stage III Prostate Adenocarcinoma AJCC v7 | Stage II Prostate Adenocarcinoma AJCC v7 | PSA Level Greater Than 0.03 | Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7United States
-
Central Finland Hospital DistrictTampere University; Tampere University Hospital; University of JyvaskylaNot yet recruiting
-
University of Alabama at BirminghamActive, not recruitingProstate CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States, Canada, Switzerland
-
Peter Busch ØstergrenRecruitingProstate Cancer MetastaticDenmark
-
Fundación de Investigación Biomédica - Hospital...CompletedProstate AdenocarcinomaSpain
-
UNICANCERBayerNot yet recruitingProstatic Cancer, Castration-Resistant
-
Fudan UniversityRecruitingProstate Cancer | Castration-resistant Prostate Cancer | Metastatic DiseaseChina
-
University GhentUniversity Hospital, GenevaActive, not recruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Metastatic | Oligometastatic CancerNorway, Spain, Belgium, Switzerland, Australia, Italy
-
Örebro University, SwedenUnknown
-
Astellas Pharma IncCompletedMetastatic Castration Resistant Prostate CancerIndia